Literature DB >> 15821113

betaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration.

E J Gold1, X Zhang, A M Wheatley, S L Mellor, M Cranfield, G P Risbridger, N P Groome, J S Fleming.   

Abstract

The mRNA expression of two activin growth factor subunits (betaA- and betaC-activin), activin receptor subunits (ActRIIA, ActRIIB) and the activin-binding protein follistatin, and peptide expression of betaA-activin and betaC-activin subunits, were examined in regenerating rat liver after partial hepatectomy (PHx). Liver samples were collected from adult, male Sprague-Dawley rats, 12-240 h (n=3-5 rats per time point) after PHx or from sham-operated controls at the same time points. Hepatocyte mitosis and apoptosis were assessed histologically and by in situ cell death detection. RT and PCR were used to assess relative gene expression. betaA- and betaC-activin peptide immunoreactivity was assessed in liver and serum samples by western blotting, whereas cellular expression was investigated by immunohistochemistry, using specific monoclonal antibodies. betaA- and betaC-activin mRNA dropped to < 50% of sham control values 12 h after PHx and remained at this level until 168 h post-PHx, when betaA-activin expression increased to three times sham control values and betaC-activin mRNA returned to pre-PHx levels. A peak in follistatin expression was observed 24-48 h post-PHx, coincident with an increase in hepatocyte mitosis. No changes were observed in ActRIIA mRNA, whereas ActRIIB expression paralleled that of betaA-activin mRNA. betaC-activin immunoreactive homo- and heterodimers were observed in regenerating liver and serum. Mitotic hepatocytes frequently contained betaC-activin immunoreactivity, whereas apoptotic hepatocytes were often immunoreactive for betaA-activin. We conclude that betaA- and betaC-activin subunit proteins are autocrine growth regulators in regenerating liver and when expressed independently lead to hepatocyte apoptosis or mitosis in a subset of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821113     DOI: 10.1677/jme.1.01657

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  20 in total

1.  Immunohistochemical labeling of the inhibin/activin betaC subunit in normal human placental tissue and chorionic carcinoma cell lines.

Authors:  Tobias Weissenbacher; Ansgar Brüning; Tanja Kimmich; Josef Makovitzky; Andrea Gingelmaier; Ioannis Mylonas
Journal:  J Histochem Cytochem       Date:  2010-05-10       Impact factor: 2.479

Review 2.  Cellular and molecular basis of liver regeneration.

Authors:  Sushant Bangru; Auinash Kalsotra
Journal:  Semin Cell Dev Biol       Date:  2020-01-22       Impact factor: 7.727

Review 3.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

4.  Activins and follistatins: Emerging roles in liver physiology and cancer.

Authors:  Emanuel Kreidl; Deniz Oztürk; Thomas Metzner; Walter Berger; Michael Grusch
Journal:  World J Hepatol       Date:  2009-10-31

5.  Over-Expression of Activin-βC Is Associated with Murine and Human Prostate Disease.

Authors:  Edward C Ottley; Karen L Reader; Kailun Lee; Francesco E Marino; Helen D Nicholson; Gail P Risbridger; Elspeth Gold
Journal:  Horm Cancer       Date:  2017-01-23       Impact factor: 3.869

6.  Rat activin-betaE mRNA expression during development and in acute and chronic liver injury.

Authors:  Elspeth J Gold; Marcel A Monaghan; Jean S Fleming
Journal:  J Mol Genet Med       Date:  2006-04-12

Review 7.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

8.  Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo.

Authors:  Elspeth Gold; Niti Jetly; Moira K O'Bryan; Sarah Meachem; Deepa Srinivasan; Supreeti Behuria; L Gabriel Sanchez-Partida; Teresa Woodruff; Shelley Hedwards; Hong Wang; Helen McDougall; Victoria Casey; Birunthi Niranjan; Shane Patella; Gail Risbridger
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

9.  Role of activin A in carbon tetrachloride-induced acute liver injury.

Authors:  Dong-Hui Wang; Yi-Nan Wang; Jing-Yan Ge; Hai-Yan Liu; Hong-Jun Zhang; Yan Qi; Zhong-Hui Liu; Xue-Ling Cui
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

10.  Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue.

Authors:  Ioannis Mylonas; Ansgar Brüning; Naim Shabani; Susanne Kunze; Markus S Kupka
Journal:  Reprod Biol Endocrinol       Date:  2010-11-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.